EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Galera Therapeutics, Inc. (GRTX) EBITDA Margin data is not available.
| Income Statement Financials | |
-- |
|
$-0.73M |
|
-- |
|
-- |
|
$1.66M |
|
$-1.66M |
|
$0.05M |
|
$-1.61M |
|
$-1.61M |
|
$-1.61M |
|
$-1.61M |
|
$-1.61M |
|
$-1.61M |
|
$-1.66M |
|
$-1.66M |
|
98.50M |
|
98.50M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$6.06M |
|
-- |
|
$0.10M |
|
$6.16M |
|
$1.14M |
|
-- |
|
-- |
|
$1.14M |
|
$0.73M |
|
$5.02M |
|
$5.02M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-0.88M |
|
-- |
|
-- |
|
$6.38M |
|
$5.50M |
|
$-0.88M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.31 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBITDA Margin |
-- |
-- |
|
-- |
|
$-0.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-220.61% |
|
-31.97% |
|
-26.05% |
|
-31.97% |
|
$0.07 |
|
$-0.01 |
|
$-0.01 |
|